AI assistant
NEOGENOMICS INC — Director's Dealing 2025
May 6, 2025
32227_dirs_2025-05-06_ed41728a-b895-46b4-8ce3-aa953f7b4a8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2025-05-02
Reporting Person: Sherman Jeffrey Scott (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-02 | Common Stock | P | 20000 | $7.5052 | Acquired | 158494 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $11.62 | 2029-12-05 | Common Stock (249169) | 249169 | Direct |
| Stock Option (Right to Buy) | $19.65 | 2030-05-11 | Common Stock (73016) | 73016 | Direct |
| Restricted Stock Unit | $0 | Common Stock (26011) | 26011 | Direct | |
| Performance Stock Unit | $0 | Common Stock (39016) | 39016 | Direct | |
| Stock Option (Right to Buy) | $16.45 | 2034-02-23 | Common Stock (77913) | 77913 | Direct |
| Performance Stock Unit | $0 | Common Stock (46606) | 46606 | Direct | |
| Restricted Stock Unit | $0 | Common Stock (59382) | 59382 | Direct | |
| Restricted Stock Unit | $0 | Common Stock (31071) | 31071 | Direct | |
| Stock Option (Right to Buy) | $13.05 | 2035-02-21 | Common Stock (214900) | 214900 | Direct |
| Restricted Stock Unit | $0 | Common Stock (126476) | 126476 | Direct |
Footnotes
F1: This balance includes 1,430 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.
F2: On December 5, 2022, Mr. Sherman was granted 249,169 stock options. The options vest ratably over four years with the first tranche vesting on December 7, 2023.
F3: On May 11, 2023, Mr. Sherman was granted 73,016 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F4: On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F5: Once vested, the shares of common stock are not subject to expiration.
F6: On May 11, 2023, Mr. Sherman was granted 39,016 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 58,524. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F7: On February 23, 2024, Mr. Sherman was granted 77,913 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F8: On February 23, 2024, Mr. Sherman was granted 46,606 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 69,910. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company
F9: On February 23, 2024, Mr. Sherman was granted 46,606 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F10: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
F11: On February 21, 2025, Mr. Sherman was granted 214,900 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F12: On February 21, 2025, Mr. Sherman was granted 126,476 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.